OpenAI and the FDA Are Holding Talks About Using AI In Drug Evaluation

High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT. WIRED Read More 

​ High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT. 

Share on Facebook

Tweet

Follow us

Save